MedPath

Treatment of Ringworm infection with Unani medicines Qurs Asfar and Roghan Narjeel

Phase 3
Conditions
Health Condition 1: B359- Dermatophytosis, unspecified
Registration Number
CTRI/2021/05/033851
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of either sex in the age group of 18-65 years.

2. Subjects confirmed by direct microscopy

3. Clinical signs and symptoms suggestive of fungal infection

Exclusion Criteria

1. Subjects on topical treatment within 2 weeks prior to entry into the study

2. Subjects on systemic therapy within 4 weeks prior to entry into the study

3. Subjects with Tineacapitis (tinea of scalp), Onychomycosis (tinea of nails) and Tineabarbae (tinea of beard)

4. Known cases of allergy to any ingredients of the study drug.

5. Subjects with history of diabetes mellitus and systemic illnessrequiring long-term treatment.

6. Lactating and pregnant women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath